Skip to main content
. 2023 Mar 16;14:1139994. doi: 10.3389/fgene.2023.1139994

FIGURE 9.

FIGURE 9

Validation of ANLN mRNA and protein expression and its association with different clinicopathological parameters in NSCLC patients. (A) qRT-PCR analysis of ANLN in four NSCLC cell lines and normal lung epithelial cell line. (B) Western blotting of ANLN in four NSCLC cell lines and normal lung epithelial cell line. (C) Immunohistochemical result of ANLN in lung cancer tissues in HPA database. (D–I) Diverse clinicopathological parameters: Sample types, patients' gender, age, weight, pathologic stage and tumor grade. *p < 0.05, **p < 0.01, ***p < 0.001. NSCLC, non-small cell lung cancer.